Showing results (41-50 of 58) with videos related to

Sort By:
Pageof 6
Journal of Cellular Biochemistry|October 9, 2024
Role of Sodium-Dependent Vitamin C Transporter-2 and Ascorbate in Regulating the Hypoxic Pathway in Cultured Glioblastoma CellsEleanor R Burgess, Citra Praditi, Elisabeth Phillips, et al.
Biochemical Pharmacology|August 19, 2014
Identification of one-electron reductases that activate both the hypoxia prodrug SN30000 and diagnostic probe EF5Jingli Wang, Chris P Guise, Gabi U Dachs, et al.
Free Radical Biology & Medicine|August 29, 2016
Pharmacokinetic and anti-cancer properties of high dose ascorbate in solid tumours of ascorbate-dependent miceElizabeth J Campbell, Margreet C M Vissers, Christina Wohlrab, et al.
Molecular Pharmacology|October 11, 2011
Diflavin oxidoreductases activate the bioreductive prodrug PR-104A under hypoxiaChristopher P Guise, Maria R Abbattista, Smitha R Tipparaju, et al.
Human Pathology|October 6, 2012
Immunohistochemical analysis of cancer stem cell markers in invasive breast carcinoma and associated ductal carcinoma in situ: relationships with markers of tumor hypoxia and microvascularityMargaret J Currie, Brooke E Beardsley, Gavin C Harris, et al.
Nutrients|August 9, 2020
Low Vitamin C Status in Patients with Cancer Is Associated with Patient and Tumor CharacteristicsRebecca White, Maria Nonis, John F Pearson, et al.
Frontiers in Oncology|March 24, 2025
Iron content of glioblastoma tumours and role of ferrous iron in the hypoxic response in vitroCitra Praditi, Eira Beverley-Stone, Malcolm Reid, et al.
BMC Cancer|December 13, 2006
Anti-vascular agent Combretastatin A-4-P modulates hypoxia inducible factor-1 and gene expressionGabi U Dachs, Andrew J Steele, Claudia Coralli, et al.
Medical Oncology (Northwood, London, England)|June 23, 2025
Portimine A maintains bioactivity following exposure to liver microsomes and cell lysates: no evidence for significant metabolic inactivationEmma M Brook, Shaya J Helem, Charlotte C M McDonald, et al.
Frontiers in Oncology|January 28, 2021
Vitamin C Administration by Intravenous Infusion Increases Tumor Ascorbate Content in Patients With Colon Cancer: A Clinical Intervention StudyGabi U Dachs, Jamish Gandhi, Christina Wohlrab, et al.
Pageof 6